Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda
NCT ID: NCT01184911
Last Updated: 2015-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2010-10-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi
NCT01120145
A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda
NCT00118027
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
NCT02793622
Preventing Malaria During Pregnancy in Epidemic-prone Areas.
NCT00142207
Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi
NCT00126906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SP
Asymptomatic parasitemic pregnant women who receive the standard dose of sulfadoxine-pyrimethamine for prevention of placental malaria
Sulfadoxine-pyrimethamine
Sulfadoxine-pyrimethamine tablets, once
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sulfadoxine-pyrimethamine
Sulfadoxine-pyrimethamine tablets, once
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Axillary temperature \<37.5 degrees C
* Informed consent
* HIV status known and negative
* Blood smear positive for falciparum malaria
Exclusion Criteria
* Axillary temperature ≥37.5 degrees C
* History of receipt of antimalarials or antibiotics with antimalarial activity\* in the past month
* Residence \> 30 km from the ANC clinic or unwillingness to return for follow-up visits
* Hemoglobin level \< 5 gm/dL
* These medications include all antimalarials, rifampin, doxycycline, clindamycin, tetracycline, erythromycin, azithromycin, chloramphenicol.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Uganda Malaria Surveillance Project
OTHER
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of California San Francisco
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronica Ades, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Scott Filler, MD, DTM&H
Role: PRINCIPAL_INVESTIGATOR
Centers for Disease Control and Prevention
Moses Kamya, MBChB, MMed, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Uganda Malaria Surveillance Project
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Infectious Disease Research Center
Tororo, Tororo, Uganda
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
UMSP website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDC5972
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.